KBC Group’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88K | Sell |
3,064
-1,018
| -25% | -$29.2K | ﹤0.01% | 1279 |
|
|
2025
Q1 | $137K | Buy |
4,082
+370
| +10% | +$12.4K | ﹤0.01% | 1293 |
|
|
2024
Q4 | $190K | Buy |
3,712
+1,519
| +69% | +$77.8K | ﹤0.01% | 1156 |
|
|
2024
Q3 | $112K | Buy |
2,193
+407
| +23% | +$20.8K | ﹤0.01% | 1213 |
|
|
2024
Q2 | $80K | Hold |
1,786
| – | – | ﹤0.01% | 1305 |
|
|
2024
Q1 | $84K | Buy |
+1,786
| New | +$84K | ﹤0.01% | 1219 |
|